News

Flagship Pioneering and its portfolio companies make news because of their transformative approaches to solving global challenges. If you have needs beyond these resources, please contact press@flagshippioneering.com.

company

year

domain

Seres Therapeutics Announces FDA Acceptance of Biologics License Application for Investigational Microbiome Therapeutic SER-109 for Recurrent C. Difficile Infection for Priority Review

Seres Therapeutics 10.26.2022

David Epstein to Step Down from Consulting Position at Flagship Pioneering

10.17.2022

Flagship Pioneering Launches Apriori Bio to Provide Variant-Proof Protection from the Greatest Viral Threats

Apriori Bio 07.11.2022

Inaugural Indigo Credit Issuance Unlocks Farmer Access to Multi-Billion Dollar Voluntary Carbon Market

Indigo Agriculture 06.29.2022

Harbinger Health and Sarah Cannon Research Institute Launch Clinical Study to Validate and Advance Development of Harbinger’s Novel Early Cancer Detection Platform

06.29.2022

Michael Severino, M.D., Joins Flagship Pioneering-Founded Tessera Therapeutics as Chief Executive Officer

Tessera Therapeutics 06.02.2022

Flagship Pioneering Unveils ProFound™ Therapeutics to Illuminate an Expanded Universe of Human Proteins with the Potential to Enable a Multitude of New Medicines

ProFound™ Therapeutics 05.26.2022

Evelo Biosciences Announces $79.2 Million Registered Direct Offering of Common Stock

Evelo Biosciences 05.25.2022

Flagship Pioneering Unveils Sonata Therapeutics to Harness Cellular Microenvironments for the Treatment of Serious Diseases

Sonata Therapeutics 05.18.2022

Evelo Biosciences Announces First Quarter 2022 Financial Results and Business Highlights

Evelo Biosciences 05.12.2022

Loading